Kallyope | Evaluate

January 12, 2023

Biopharma’s venture year ends with another dip

Last year saw plenty of cash deployed, but with sums shrinking each quarter the stage is set for further retrenchment.

Venture funding stays strong despite the gloom

But how long can the money keep rolling in?

April 08, 2020

Biopharma venture investors shrug off Covid-19

First-quarter venture investments barely register the pandemic - huge cash reserves should protect funding for biotech start-ups this year.

February 22, 2017

Asco-SITC – Oncology could give gutsy biotechs another chance